Lantheus Holdings (LNTH) Long-Term Deferred Tax (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Long-Term Deferred Tax came in at $89.1 million in Q1 2026, down 47.23% year-on-year from $168.9 million in Q1 2025, and down 18.38% on a QoQ basis from $109.2 million in Q4 2025.

Lantheus Holdings (LNTH) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Long-Term Deferred Tax data on file, last reported at $89.1 million in Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax fell 47.23% year-over-year to $89.1 million in Q1 2026; TTM through Mar 2026 was $89.1 million, a 47.23% decrease from a year earlier, with the FY2025 full-year figure at $109.2 million, down 35.85% from the prior year.
  • Long-Term Deferred Tax for Q1 2026 stood at $89.1 million, down from $109.2 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for LNTH reached as high as $170.2 million in Q4 2024 and fell as low as $46.8 million in Q3 2022.
  • Historically, Long-Term Deferred Tax has averaged $120.5 million across 5 years, with a median of $134.2 million in 2023.
  • Across the five-year window, Long-Term Deferred Tax soared 225.15% in 2023 and plunged 47.23% in 2026, its largest moves.
  • Year by year, Long-Term Deferred Tax stood at $110.6 million in 2022, then surged by 35.75% to $150.2 million in 2023, then climbed by 13.34% to $170.2 million in 2024, then tumbled by 35.85% to $109.2 million in 2025, then dropped by 18.38% to $89.1 million in 2026.
  • Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $89.1 million in Q1 2026, $109.2 million in Q4 2025, and $107.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 89.12 Mn
Dec 31, 2025 109.20 Mn
Sep 30, 2025 107.45 Mn
Jun 30, 2025 138.26 Mn
Mar 31, 2025 168.89 Mn
Dec 31, 2024 170.23 Mn
Sep 30, 2024 144.64 Mn
Jun 30, 2024 151.19 Mn
Mar 31, 2024 138.90 Mn
Dec 31, 2023 150.20 Mn
Sep 30, 2023 152.19 Mn
Jun 30, 2023 134.20 Mn
Mar 31, 2023 133.87 Mn
Dec 31, 2022 110.65 Mn
Sep 30, 2022 46.81 Mn
Jun 30, 2022 55.16 Mn
Mar 31, 2022 47.87 Mn
Dec 31, 2021 62.76 Mn
Sep 30, 2021 66.49 Mn
Jun 30, 2021 64.78 Mn